Europe's battle against Aedes mosquitoes: growing threat of mosquito-borne diseases ECDC_EU mosquitos infection mosquitoes mosquitoborne disease transmisson publichealth
By Neha MathurJun 26 2023Reviewed by Lily Ramsey, LLM In a recent report published on the European Centre for Disease Prevention and Control website, the agency described how cases of all types of mosquito-borne diseases are increasing in Europe.
Per recent ECDC data, Aedes albopictus, the well-recognized vector of dengue and chikungunya viruses, is spreading north and westwards in Europe. Likewise, Aedes aegypti , another mosquito species that transmits yellow fever, West Nile, and Zika viruses, has established itself in Cyprus and now spreading to other European countries.
Around ten years ago, i.e., in 2013, the Aedes albopictus mosquito species had established in eight EU/EEA countries, while 114 regions were affected. However, now its incidence has dramatically increased globally in recent decades. Intriguingly, Aedes aegypti causes dengue globally, and Aedes albopictus causes dengue in Europe. However, both species breed in or near human inhabitants.
Notably, older adults and immunocompromised people are at a higher risk of developing West Nile fever, a fatal, neuroinvasive disease for which no prophylaxis or treatment is available. …In recent years we have seen a geographical spread of invasive mosquito species to previously unaffected areas in the EU/EEA. If this continues, we can expect to see more cases and possibly deaths from diseases such as dengue, chikungunya, and West Nile fever.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Europe’s bank resolution authority seeks ‘firepower’ to deal with collapsed lenders\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Consulte Mais informação »
Tri-nation Gas Swap Agreement Could Transform Europe’s Energy Market | OilPrice.comThe gas swap agreement is anticipated to grow by 70% this year, bolstered by the expansion of Iran’s gas transit infrastructure and a new gas import agreement with Turkmenistan.
Consulte Mais informação »
NHS trailing behind other major nations on life expectancy, study findsResearchers warn Britain's poor performance across several different major disease groups and health conditions including cancer, heart attacks and strokes - judged by preventable deaths - should be a serious concern for political leaders and policymakers.
Consulte Mais informação »
Public health concerns: monitoring e-cigarette sales key to preventing youth tobacco usePublic health concerns: monitoring e-cigarette sales key to preventing youth tobacco use CDCMMWR publichealth health ecigarettes vape vaping tobacco nicotine
Consulte Mais informação »
Factors associated with acute kidney injury among preterm infants administered vancomycin: a retrospective cohort study - BMC PediatricsBackground Vancomycin (VCM) is a widely used antibiotic for the treatment of gram-positive microorganisms, with some nephrotoxic effects. Recent studies have suggested that piperacillin-tazobactam (TZP) aggravates VCM-induced nephrotoxicity in adults and adolescents. However, there is a lack of research investigating these effects in the newborn population. Therefore, this study investigates whether the concomitant use of TZP with VCM use increases the risk of acute kidney injury (AKI) and to explore the factors associated with AKI in preterm infants treated with VCM. Methods This retrospective study included preterm infants with birth weight | 1,500 g in a single tertiary center who were born between 2018 and 2021 and received VCM for a minimum of 3 days. AKI was defined as an increase in serum creatinine (SCr) of at least 0.3 mg/dL and an increase in SCr of at least 1.5 times baseline during and up to 1 week after discontinuation of VCM. The study population was categorized as those with or without concomitant use of TZP. Data on perinatal and postnatal factors associated with AKI were collected and analyzed. Results Of the 70 infants, 17 died before 7 postnatal days or antecedent AKI and were excluded, while among the remaining participants, 25 received VCM with TZP (VCM + TZP) and 28 VCM without TZP (VCM—TZP). Gestational age (GA) at birth (26.4 ± 2.8 weeks vs. 26.5 ± 2.6 weeks, p = 0.859) and birthweight (750.4 ± 232.2 g vs. 838.1 ± 268.7 g, p = 0.212) were comparable between the two groups. There were no significant differences in the incidence of AKI between groups. Multivariate analysis showed that GA (adjusted OR: 0.58, 95% CI: 0.35–0.98, p = 0.042), patent ductus arteriosus (PDA) (adjusted OR: 5.23, 95% CI: 0.67–41.05, p = 0.115), and necrotizing enterocolitis (NEC) (adjusted OR: 37.65, 95% CI: 3.08–459.96, p = 0.005) were associated with AKI in the study population. Conclusions In very low birthweight infants, concomitant use of TZP did not increase the r
Consulte Mais informação »
Effects of corrective and breathing exercises on respiratory function of older adults with a history of COVID-19 infection: a randomized controlled trial - BMC Complementary Medicine and TherapiesBackground Patients with a history of COVID-19 infection may suffer from different physical problems. This study aimed to investigate the effect of corrective and breathing exercises on improving respiratory function among patients with a history of COVID-19 infection. Methods In this clinical trial study, thirty elderlies with a history of COVID-19 disease were divided into two groups (mean age 63.60 ± 3.56 experimental, 59.87 ± 2.99 control groups) based on the study inclusion criteria. Exercise interventions included two sections- breathing exercises and corrective exercises in the cervical and thoracic spine. The spirometry test, craniovertebral angle, and thoracic kyphosis test were used. To evaluate differences between variables, paired-samples t-test and ANCOVA were used (p-value 0.01). The Eta-squared value of 0.51 for the Craniovertebral angle and the SPO2 indicates a large effect size. Conclusions The results showed the combination of corrective and breathing exercises could improve pulmonary function and correct cervical and thoracic posture in patients with a history of COVID-19 infection. Therefore, corrective and breathing exercises can be helpful as a complementary treatment along with pharmaceutical therapy to reduce chronic pulmonary complications in patients infected with COVID-19. Trial registration This research was registered in the Iranian Registry of Clinical Trials (IRCT registration number: IRCT20160815029373N7, First trial registration: 23/08/2021, Registration date: 01/09/2021).
Consulte Mais informação »